Emcure Pharmaceuticals Limited IPO

Emcure Pharmaceuticals Limited is an Indian pharmaceutical company headquartered in Pune, Maharashtra. It was founded in 1981 by Satish Mehta. The company focuses on developing, manufacturing, and marketing a broad range of pharmaceutical products. Here are some key points about Emcure Pharmaceuticals…

1. Product Range: Emcure manufactures a variety of pharmaceutical products including tablets, capsules, injectables, and APIs (Active Pharmaceutical Ingredients). The company’s product portfolio spans multiple therapeutic areas such as cardiology, pain and analgesics, HIV, gynecology, nephrology, and anti-infectives.
2. Global Presence: Emcure has a significant presence in over 70 countries across the globe. It operates subsidiaries in several countries, including the United States, Canada, Brazil, and the UK.
3. Research and Development: Emcure places a strong emphasis on R&D and innovation. It operates several R&D facilities that focus on the development of new drugs, complex generics, and biosimilars. The company invests heavily in research to bring new and effective treatments to the market.
4. Biosimilars: Emcure is a key player in the biosimilars segment. Biosimilars are biologic medical products that are almost identical copies of an original product that is manufactured by a different company. Emcure has developed several biosimilars, which are marketed in various countries.
5. Corporate Social Responsibility (CSR): Emcure is involved in various CSR activities, focusing on healthcare, education, and community development. The company runs several initiatives aimed at improving access to healthcare and supporting education for underprivileged communities.
6. Recent Developments: Emcure has been active in the development of treatments for COVID-19. The company has been involved in manufacturing and supplying antiviral drugs and has also worked on the development of a COVID-19 vaccine in collaboration with other organizations.
7. Leadership: The company is led by Satish Mehta, the founder, and Managing Director, along with a team of experienced professionals who oversee various aspects of the business.

Emcure Pharmaceuticals continues to grow and expand its reach, focusing on innovation and quality in the pharmaceutical industry.

Emcure Pharmaceuticals Limited IPO Tentative Timetable

Emcure Pharmaceuticals Limited IPO Details

Emcure Pharmaceuticals Limited IPO Lot Size

Emcure Pharmaceuticals Limited IPO Allotment Status

Click Here To Check IPO Allotment Status Emcure Pharmaceuticals Limited IPO

Click Here To Get ASBA Forms Emcure Pharmaceuticals Limited IPO

Company Financials:

Company Promoters:

Satish Mehta and Sunil Mehta are the company promoters.

Objects of this Issue:

• Repayment and/ or prepayment of all or a portion of certain outstanding borrowings availed by the company.
• General corporate purposes.

Registrar & Company Details